文献速递瓣膜外科

快速部署瓣膜假体策略治疗主动脉瓣心内膜炎的评估

Evaluation of a rapid deployment prosthesis strategy for the treatment of aortic valve endocarditis.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

本研究评估了使用EDWARDS INTUITY Elite快速部署瓣膜假体治疗自体主动脉瓣心内膜炎(NVE)或人工主动脉瓣心内膜炎(PVE)患者的手术结局。2019年2月至2020年6月,25例患者(NVE 9例,占36%;PVE 16例,占64%)在本机构接受了INTUITY瓣膜。平均EuroSCORE II为13.4%。结论认为,使用该瓣膜系统可安全地实施NVE和PVE手术,并可能适用于广泛感染、根组织脆弱和需要根部重建的根部脓肿病例。

要点

  • 25例主动脉瓣心内膜炎患者(NVE 9例,PVE 16例)接受INTUITY快速部署瓣膜,平均EuroSCORE II 13.4%。
  • 44%患者同期行主动脉根部补片成形,16%行冠状动脉旁路移植术,12%行二尖瓣修复,8%行升主动脉替换。
  • 随访期间无复发性心内膜炎,1例死于术前已存在的多系统器官衰竭。

核心结论

  • 使用EDWARDS INTUITY Elite瓣膜系统可安全地实施主动脉瓣NVE和PVE手术。
  • 该手术可能适用于广泛感染、根组织脆弱和需要根部重建的根部脓肿病例。
  • 在本机构,快速部署主动脉瓣置换策略已成为手术治疗心内膜炎的重要工具。

研究设计与样本

  • 本研究为单中心病例系列,纳入2019年2月至2020年6月在本机构接受INTUITY瓣膜的25例主动脉瓣心内膜炎患者(NVE 9例,占36%;PVE 16例,占64%)。
  • 收集了术前、术中和随访数据。

主要发现

  • 平均EuroSCORE II为13.4%。
  • 11例(44%)患者同期接受主动脉根部补片成形,4例(16%)接受冠状动脉旁路移植术,3例(12%)接受二尖瓣修复,2例(8%)接受升主动脉替换。
  • 体外循环时间和主动脉阻断时间分别为124±56分钟和75±39分钟。
  • 平均重症监护室停留时间为5天。
  • 植入假体平均尺寸为25±2毫米,术后3个月平均假体跨瓣压差为9±4 mmHg。

临床怎么用

  • 作者认为,使用EDWARDS INTUITY Elite瓣膜系统可安全地实施主动脉瓣NVE和PVE手术。
  • 作者认为,该手术可能适用于广泛感染、根组织脆弱和需要根部重建的根部脓肿病例。
  • 本研究中心的做法是,快速部署主动脉瓣置换策略已成为手术治疗心内膜炎的重要工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to evaluate the surgical outcome of patients suffering from native aortic valve (NVE) or prosthetic aortic valve endocarditis (PVE) treated with the EDWARDS INTUITY Elite rapid-deployment valve prosthesis. METHODS: Between February 2019 and June 2020, 25 patients suffering from NVE (n = 9; 36%) and PVE (n = 16; 64%) of the aortic valve received an INTUITY valve at our institution. Preoperative, operative and follow-up data were collected. RESULTS: In our cohort, the mean EuroSCORE II was 13.4%. Eleven patients (44%) received concomitant aortic root patch plasty. Four patients (16%) received coronary artery bypass graft surgery, 3 patients (12%) received mitral valve repair and 2 patients (8%) underwent replacement of the ascending aorta. The cardiopulmonary bypass and aortic cross-clamp times were 124 ± 56 and 75 ± 39 min, respectively. The mean intensive care unit stay was 5 days. The mean size of the implanted prostheses was 25 ± 2 mm and the mean prosthesis transvalvular gradient 3 months after surgery was 9 ± 4 mmHg. During follow-up, no case of recurrent endocarditis occurred, 1 patient died of multisystem organ failure which had already been present preoperatively. CONCLUSIONS: Surgery for NVE and PVE of the aortic valve may be safely performed using the EDWARDS INTUITY Elite valve system. This procedure could be well implemented in cases with extensive infection, fragile root tissue and root abscesses requiring root reconstruction. In our institution, the rapid-deployment aortic valve replacement strategy has become an important tool in the armamentarium of the surgical endocarditis treatment.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Belyaev S, Herrmann FEM, Dashkevich A, et al. Evaluation of a rapid deployment prosthesis strategy for the treatment of aortic valve endocarditis. Eur J Cardiothorac Surg. 2022. PMID: 35076056. doi:10.1093/ejcts/ezac018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。